Primary partners - Desmond Tutu HIV Foundation, Kenya Medical Research Institute (KEMRI), Who: Core partner - University of Washington POWER – Prevention Options for Women Evaluation Research.Objectives: The project aims to develop evidence-based business cases and coordinated investment strategies for introduction support country level regulatory approval, policy development, program planning, and marketing and implementation strategies facilitate and conducting implementation science and provide technical assistance and support for health systems strengthening with rapid use of data to identify and address implementation bottlenecks throughout the value chain. What: Provide targeted support to expedite and sustain access to ARV-based HIV prevention products in countries and among populations where most needed. Primary partners - Avenir Health, FSG, LVCT Health, LSHTM, McCann Health, Pangaea Who: Core partners - FHI 360, Wits RHI, AVAC OPTIONS – Optimizing Prevention Technology Introduction On Schedule. The US Agency for International Development’s (USAID) Office of HIV/AIDS is supported five interconnected projects on ARV-based HIV prevention product introduction and access, the Microbicide Product Introduction Initiative (MPii) agreements, that run from 2015-2020. USAID Microbicide Product Introduction Initiative (MPii)
0 Comments
Leave a Reply. |